INTERLEUKIN-2 IMMUNOCONJUGATE, A CD40 AGONIST, AND OPTIONALLY A PD-1 AXIS BINDING ANTAGONIST FOR USE IN METHODS OF TREATING CANCER

• 收藏
• 分享

专利权人:

Hoffmann-La Roche Inc.

发明人:

Christian KLEIN,Valeria G. NICOLINI,Pablo UMAÑA

申请号：

US16595845

公开号：

US20200188526A1

申请日:

2019.10.08

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The invention provides compositions and methods for treating cancer, the method comprising administering an IL-2 immunoconjugate, a CD40 agonist and optionally a PD-1 axis binding antagonist.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/